Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.

Different outcomes among patients hospitalized for bleeding after starting anticoagulation could influence choice of anticoagulant. We compared length of hospitalization, proportion of Intensive Care Unit (ICU) admissions, ICU length of stay, and 30- and 90-day mortality for adults with atrial fibri...

Full description

Bibliographic Details
Main Authors: Blake Charlton, Gboyega Adeboyeje, John J Barron, Deborah Grady, Jaekyu Shin, Rita F Redberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5874024?pdf=render

Similar Items

Similar Items